Aura Biosciences, Inc. announced that on April 3, 2023, Mark De Rosch informed company of his intent to resign as Chief Operating Officer of the company. Mr. De Rosch's resignation will be effective on April 30, 2023. Mr. De Rosch will provide transition services for the Company for a 30 day period commencing on the date of his resignation, which such period may be extended for another 30 days by the Company upon written notice to Mr. De Rosch.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.25 USD | +3.13% | +4.32% | -18.17% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.17% | 359M | |
+54.05% | 58.71B | |
-2.02% | 41.31B | |
+37.77% | 39.2B | |
-10.22% | 27.4B | |
+13.42% | 26.55B | |
-21.60% | 18.98B | |
+2.89% | 12.51B | |
+22.40% | 11.94B | |
+27.49% | 12.08B |
- Stock Market
- Equities
- AURA Stock
- News Aura Biosciences, Inc.
- Aura Biosciences, Inc. Announces Resignation of Mark De Rosch as Chief Operating Officer, Effective April 30, 2023